Published in
Lippincott, Williams & Wilkins, Anti-Cancer Drugs, 2(32), p. 218-221, 2020
DOI: 10.1097/cad.0000000000001011
Links
Tools
Prolonged benefit to pembrolizumab in anaplastic oligodendroglioma patient with mismatch repair deficiency: a case report
Journal article published in 2020 by
Marta Padovan,
Mario Caccese 
,
Vittorina Zagonel,
Giuseppe Lombardi
,
Vittorina Zagonel,
Giuseppe Lombardi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 